Results 21 to 30 of about 37,095 (249)

Cannabinoid Hyperemesis Syndrome [PDF]

open access: yes, 2015
Legalization of marijuana use will increase the number of people who will become long-term users. A prior medical record review study in Australia, in 2004, identified 19 chronic marijuana users who entered the emergency department with recurrent ...
Heise, Lynn
core   +2 more sources

Ondansetron and Hypothermia Induced Cardiac Arrest in a 97-Year-Old Woman: A Case Report

open access: yesCardiovascular Innovations and Applications, 2022
Background: Ondansetron and hypothermia are both known to induce bradycardia or QT interval prolongation, thus placing affected patients at risk of cardiac arrest.
Keith Sai Kit Leung   +8 more
doaj   +1 more source

Ondansetron Exposure Changes in a Pregnant Woman [PDF]

open access: yes, 2016
Pregnancy results in many physiologic changes that can alter the pharmacokinetic profiles of medications used during pregnancy. One of the primary factors leading to these pharmacokinetic changes is altered activity of drug-metabolizing enzymes ...
Caritis, Steve N.   +6 more
core   +1 more source

Magnesium sulphate in the treatment of acute asthma: evaluation of current practice in adult emergency departments [PDF]

open access: yes, 2009
Background: A recent meta-analysis showed that intravenous and nebulised magnesium sulphate have similar levels of evidence to support their use in the treatment of acute asthma in adults. This consisted of weak evidence of effect on respiratory function
Goodacre, S., Jones, L.A.
core   +1 more source

The association between ondansetron use and mortality risk of traumatic brain injury patients: a population-based study

open access: yesFrontiers in Pharmacology
Background:Traumatic brain injury (TBI) patients suffer high risks of mortality. Ondansetron has been verified to be effective in improving the prognosis of some kinds of critically ill patients. We design this study to explore whether ondansetron use is
Ruoran Wang   +3 more
doaj   +1 more source

Elucidation of the Crystal Structures and Dehydration Behaviors of Ondansetron Salts

open access: yesCrystals, 2019
In drug development, it is extremely important to evaluate the solubility and stability of solid states and to immediately determine the potential for development.
Ryo Mizoguchi, Hidehiro Uekusa
doaj   +1 more source

Ondansetron‐induced pseudoallergy with non‐ischemic myocardial injury: A rare case report of Kounis syndrome

open access: yesClinical Case Reports, 2022
Ondansetron is an FDA‐approved selective serotonin 5‐HT3 receptor commonly indicated as an anti‐emetic agent for nausea and vomiting. It is rare to observe fatal reactions from ondansetron despite having no allergies or previous exposure.
Eden Firew   +5 more
doaj   +1 more source

The role of ondansetron in the management of cholestatic or uremic pruritis - a systematic review [PDF]

open access: yes, 2012
Pruritus associated with hepatic or renal failure can be a troublesome symptom, refractory to treatment, associated with significant physical and emotional distress, and reduction in quality of life for patients already burdened with chronic disease ...
Clark, Katherine   +4 more
core   +1 more source

Effect of ondansetron on prevention of post-induction hypotension in elderly patients undergoing general anesthesia: A randomized, double-blind placebo-controlled clinical trial

open access: yesSaudi Journal of Anaesthesia, 2015
Background: Elderly patients are susceptible to post-induction hypotension. Volume loading and vasopressors for prevention of hypotension in elderly patients may increase perioperative cardiovascular risks.
Mohammad Golparvar   +3 more
doaj   +1 more source

Severe acute dystonia induced by ondansetron in a paediatric patient: a case report

open access: yesEmergency Care Journal
Ondansetron, a 5-HT3 serotonin receptor antagonist, is widely used to manage nausea and vomiting, particularly in postoperative recovery, chemotherapy, and paediatric gastroenteritis.
Kishore Nagaraju   +4 more
doaj   +1 more source

Home - About - Disclaimer - Privacy